http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-864356-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-60
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-60
filingDate 1957-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1961-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-864356-A
titleOfInvention Improvements in or relating to heterocyclic compounds and the manufacture thereof
abstract The invention comprises phenthiazine derivatives of the general formula: <FORM:0864356/IV (b)/1> and their acid addition and quaternary ammonium salts (wherein X is a halogen atom or a C1-8 alkoxy radical or trihalomethyl radical, R1 and R2 when taken singly each represent a C1-8 alkyl radical and when taken collectively represent an alkylene or oxaalkylene radical connected to the amino nitrogen to form a heterocyclic ring), also sulphoxides thereof and their acid addition and quaternary ammonium salts, and N,5-dioxides thereof and their acid addition salts; and the preparation thereof by reacting a condensation product of a phenthiazine of the general formula: <FORM:0864356/IV (b)/2> and an epihalohydrin with a secondary amine of the general formula: <FORM:0864356/IV (b)/3> followed, if desired, by the conversions illustrated in the examples below. Acid addition salts which may be prepared are the hydrobromide, hydrochloride, hydroiodide, nitrate, phosphate, sulphate, acetate ascorbate, benzoate, citrate, glycolate, lactate, salicylate, succinate and tartrate salts. Quaternary ammonium salts which may be prepared are the metho-bromide andiodide, etho-bromide and - chloride, benzyl-chloride and ethyl-p-toluenesulphonate. The compounds of the invention have therapeutic properties. In examples: (1) the condensation product of 2-chlorophenthiazine and epichlorohydrin is heated with dimethylamine to give 10-(3-dimethylamino-2- hydroxypropyl)- 2- chlorophenthiazine, which may be oxidised by hydrogen peroxide to the corresponding N,5-dioxide; (2) the product of (1) is treated in ether with ethereal hydrogen chloride to give the corresponding hydrochloride, which may be oxidised by hydrogen peroxide to the sulphoxide hydrochloride; (3) the initial condensation product of (1) is heated with 2, 2-dimethylpyrrolidine to give 10-[3-(2, 2-dimethyl-1-pyrrolidyl)-2-hydroxypropyl]-2-chlorophentiazine; (4) the product of (3) is converted into the hydrochloride by the method of (2). Alternative substituents specified, some of which are illustrated in a list of further products, are: X = Br,F,I,OCH3,-OC2H5-, OC4H9-, CF3 and CCl3, <FORM:0864356/IV (b)/4> = diethylamino, n-methylisopropylamino, 1-pyrrolidyl, piperidyl or morpholinyl. Specifications 686,069 and 716,205 are referred to.
priorityDate 1956-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457765275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449831254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410637400
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583629
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559487
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21225539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54670067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID674
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410443241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID414773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407364030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420529491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6638
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9321
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414863366

Total number of triples: 56.